Technology

Rachel Curtis, MD, a fourth-year resident at Queen's University, Kingston, Ontario, Canada, discusses the highlights from a study comparing a smartphone-compatible device versus traditional direct ophthalmoscopy in teaching medical students how to complete an optic nerve examination.

Precision injection device can improve patient and physician experiences.

Investigators find technology aids instruction of students.

Tom Mitro, president, COO of Aerie Pharmaceuticals, discusses the key highlights from an industry panel discussion titled "Innovate without borders," held during the Glaucoma 360 New Horizons Forum, including the company's role in expanding into the global glaucoma therapeutics market.

Intraocular drainage surgery may have a future for treating issues.

Consider ideas about outflow pathways, neuroprotection.

Phakic lenses are proving to be excellent additions to refractive practices.

A new therapy provides noninvasive nighttime IOP control by programming the desired pressure into the device, explained John Berdahl, MD, during the New Horizons Forum.

Glaukos Corporation's COO Chris Calcaterra gives an update on the company's latest 24-month phase 2b data for its iDose TR sustained-release travoprost implant, next steps for securing FDA approval, and his outlook for 2021.

Noninvasive option reduces IOP in patients with glaucoma.

Emerging technology may facilitate individualized care, disease management.

Study evaluates the impact of surgical procedure on visual outcomes in patients.

All syringes used for intravitreal injections have pros and cons. Some recently marketed and forthcoming products are coming closer to meeting “ideal” criteria.

Procedure increases lens stability and improves visual acuity in patients.

In light of an unprecedented year filled with technological advancements and pivots, Joshua Mali, MD, offers his top 5 predictions in ophthalmology for 2021.

Novel OCT system with AI-based image analysis holds promise.

Newest advances improving ophthalmologists’ performance in operating room.

Programs use detection and treatment to ease burden of eye disease.

Ram Liebenthal, U.S. general manager for Heidelberg Engineering, discusses how the company continues to invest in the Spectralis platform in terms of hardware and software improvements.

During Day 1 of AAO 2020, Carl Awh, MD, discusses the Micro-Vacuum Pick, a device for peeling internal limiting membranes that's providing vitreoretinal surgeons an alternative to forceps during surgeries.

Algorithm detects, stratifies severity of disease, facilitates early diagnosis.

Optics block out-of-focus and stray light, allow continuum of vision.

Device allows visually impaired to recognize shapes, distinguish between light and dark.

Dilation may be an important step to reduce the rate of ungradable images

Technology with potential to improve treatment and evaluation of cortical visual impairment.

Social media sites offer physicians an opportunity for patient education.

Newly cleared technology for laser cataract gives ophthalmologists another tool.

Robotic-assisted procedures are proving more precise in every way when compared with manual procedures: automated assistance controls tremor, reduces fatigue, and helps avoid inadvertent injury.

Glaucoma Research Foundation (GRF) Ambassadors webinar provides platform for idea-sharing by ophthalmologists